Nick Van Dyk | CureTalks
Nicolas van Dyk (Nick) is a senior executive with a major media company, and in his spare time, he is the guitarist / songwriter for the rock band Redemption. He is in three years of complete remission following aggressive chemotherapy including tandem transplants and believes that Total Therapy represents a potentially curative option for a meaningful subset of newly diagnosed patients and can exceed a 50% cure rate for patients in the right population. Nick chronicles his myeloma journey in his personal blog,www.nvdmyeloma.blogspot.com
Related Talks
Minimal Residual Disease with Dr. Guido Tricot
What is the difference, if there is one, between MRDzero and MRD negative? Do these definitions vary from institution to institution or are…
High Risk Multiple Myeloma Prognosis with Dr. Sagar Lonial
We are talking about high-risk multiple myeloma and its prognosis with Dr. Sagar Lonial this August. Make sure to REGISTER in advance to…
High Risk Multiple Myeloma Survival w/ Dr. Rafael Fonseca of Mayo Clinic
What does high-risk means in a patient who is diagnosed with multiple myeloma? What are the markers that determine the most common sub-category…
Exploring Monoclonal Antibody Therapies in Myeloma w/ Dr. Chanan Khan of Mayo Clinic
Dr. Asher A. Chanan Khan of Mayo Clinic, Jacksonville discusses monoclonal antibody therapies in Myeloma. Dr. Khan is dedicated to advancing and discovering…
Dana Farber’s Dr. Richardson on Transplants in Myeloma
To Transplant or Not To Transplant: Hear it from world renowned myeloma expert, Dr. Paul Richardson of Harvard's Dana Farber Cancer Center.